Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

T/Tn antigen vaccine is effective and safe in preventing recurrence of advanced human breast carcinoma.

Springer GF, Desai PR, Tegtmeyer H, Carlstedt SC, Scanlon EF.

Cancer Biother. 1994 Spring;9(1):7-15.

PMID:
7812359
2.

T/Tn antigen vaccine is effective and safe in preventing recurrence of advanced breast carcinoma.

Springer GF, Desai PR, Spencer BD, Tegtmeyer H, Carlstedt SC, Scanlon EF.

Cancer Detect Prev. 1995;19(4):374-80.

PMID:
7553680
4.

Results of the first phase I clinical trial of the novel II-key hybrid preventive HER-2/neu peptide (AE37) vaccine.

Holmes JP, Benavides LC, Gates JD, Carmichael MG, Hueman MT, Mittendorf EA, Murray JL, Amin A, Craig D, von Hofe E, Ponniah S, Peoples GE.

J Clin Oncol. 2008 Jul 10;26(20):3426-33. doi: 10.1200/JCO.2007.15.7842.

PMID:
18612158
5.

Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy.

Springer GF.

J Mol Med (Berl). 1997 Aug;75(8):594-602. Review.

PMID:
9297627
6.
7.

Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine.

Holmberg LA, Oparin DV, Gooley T, Lilleby K, Bensinger W, Reddish MA, MacLean GD, Longenecker BM, Sandmaier BM.

Bone Marrow Transplant. 2000 Jun;25(12):1233-41.

8.

Immunohistochemical expression of T, Tn and sialyl-Tn antigens and clinical outcome in human breast carcinoma.

Imai J, Ghazizadeh M, Naito Z, Asano G.

Anticancer Res. 2001 Mar-Apr;21(2B):1327-34.

PMID:
11396208
9.

Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.

Cance WG, Carey LA, Calvo BF, Sartor C, Sawyer L, Moore DT, Rosenman J, Ollila DW, Graham M 2nd.

Ann Surg. 2002 Sep;236(3):295-302; discussion 302-3.

10.

Management of stage IV glottic carcinoma: therapeutic outcomes.

Spector GJ, Sessions DG, Lenox J, Newland D, Simpson J, Haughey BH.

Laryngoscope. 2004 Aug;114(8):1438-46.

PMID:
15280724
12.

Autologous tumor vaccine lowering postsurgical recurrent rate of hepatocellular carcinoma.

Peng B, Liang L, Chen Z, He Q, Kuang M, Zhou F, Lu M, Huang J.

Hepatogastroenterology. 2006 May-Jun;53(69):409-14.

PMID:
16795983
13.

Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.

Trombetta M, Julian TB, Werts DE, McWilliams W, Kim Y, Miften M, Parda D.

Am J Clin Oncol. 2009 Jun;32(3):314-8. doi: 10.1097/COC.0b013e31818af0b9.

PMID:
19451803
14.
15.

Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.

Davidson B, Gotlieb WH, Ben-Baruch G, Kopolovic J, Goldberg I, Nesland JM, Berner A, Bjåmer A, Bryne M.

Gynecol Oncol. 2000 Apr;77(1):35-43.

PMID:
10739688
16.

Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.

Le QT, Fu KK, Kaplan M, Terris DJ, Fee WE, Goffinet DR.

Cancer. 1999 Nov 1;86(9):1700-11.

PMID:
10547542
17.

Surgical treatment for invasive lobular carcinoma of the breast.

Hussien M, Lioe TF, Finnegan J, Spence RA.

Breast. 2003 Feb;12(1):23-35.

PMID:
14659352
18.

Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells.

Karcher J, Dyckhoff G, Beckhove P, Reisser C, Brysch M, Ziouta Y, Helmke BH, Weidauer H, Schirrmacher V, Herold-Mende C.

Cancer Res. 2004 Nov 1;64(21):8057-61.

19.

Stage 0 to stage III breast cancer in young women.

Gajdos C, Tartter PI, Bleiweiss IJ, Bodian C, Brower ST.

J Am Coll Surg. 2000 May;190(5):523-9.

PMID:
10801018
20.

Vaccination with Theratope (STn-KLH) as treatment for breast cancer.

Holmberg LA, Sandmaier BM.

Expert Rev Vaccines. 2004 Dec;3(6):655-63. Review.

PMID:
15606349

Supplemental Content

Support Center